{"id":"W3107140765","doi":"10.2967/jnumed.120.249029","title":"First Experiences with <sup>177</sup>Lu-PSMA Therapy in Combination with Pembrolizumab or After Pretreatment with Olaparib in Single Patients","year":2020,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Olaparib; Medicine; Prostate cancer; Internal medicine; Oncology; Immunotherapy; Urology; Combination therapy; Prostate-specific antigen; Cancer; DNA; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000133153,0.0002155299,0.0005375292,0.0002472275,0.00004526919,0.00001975608,0.0001072164,0.00005675569,0.000399259],"category_scores_gemma":[0.00004883666,0.00009349697,0.00003004639,0.0005577438,0.0002306046,0.0002389006,0.00001633489,0.0003212088,0.000003164528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003301394,"about_ca_system_score_gemma":0.0001795008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005998651,"about_ca_topic_score_gemma":0.00007646238,"domain_scores_codex":[0.9981874,0.00005786261,0.0003918938,0.0002203924,0.0008638178,0.0002786252],"domain_scores_gemma":[0.9991013,0.00005912556,0.0002077253,0.0001303125,0.0002434861,0.0002580895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2008663,0.004199897,0.6114721,0.0002412516,0.0004136242,0.005239335,0.1656306,0.0002175841,0.0001306206,0.000005317011,0.001101282,0.01048212],"study_design_scores_gemma":[0.1909942,0.2670874,0.4583133,0.006418566,0.0002322129,0.0005797187,0.06764852,0.001349301,0.0004827135,0.000009507853,0.006458428,0.0004260964],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878737,0.0005691836,0.000007620194,0.01050833,0.00002120501,0.0006176964,0.000001444955,0.00001127026,0.0003895975],"genre_scores_gemma":[0.9982498,0.0004044185,0.0002929156,0.0007905501,0.0001103265,0.00003116319,0.000006735347,0.0000382428,0.00007584523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2628875,"threshold_uncertainty_score":0.4371606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02740922171934527,"score_gpt":0.2722952437973554,"score_spread":0.2448860220780102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}